Advertisement

Diagnosis, management, and treatment of hepatitis C: An update§

Authors

  • Marc G. Ghany,

    1. Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Department of Health and Human Services, Bethesda, MD
    Search for more papers by this author
  • Doris B. Strader,

    1. Division of Gastroenterology/Hepatology, Fletcher Allen Health Care, University of Vermont College of Medicine, Burlington, VT
    Search for more papers by this author
  • David L. Thomas,

    1. Infectious Disease, The Johns Hopkins University School of Medicine, Baltimore MD
    Search for more papers by this author
  • Leonard B. Seeff

    Corresponding author
    1. Liver Disease Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD
    • Liver Disease Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Building 31, Room 9A27, Bethesda, MD 20892
    Search for more papers by this author
    • fax: 301-480-7926


  • Disclaimer Statement: The views expressed in these guidelines do not necessarily represent the views of the Department of Health and Human Services, the National Institutes of Health, the National Institute of Diabetes and Digestive and Kidney Diseases, or the United States Government.

  • Potential conflict of interest: Drs. Marc Ghany, Leonard Seeff, and Doris Strader have no financial relationships to declare. Dr. David Thomas was on the Advisory Board of Merck, Sharpe and Dohme at the time of writing but has since resigned from this position.

  • §

    All American Association for the Study Liver Diseases (AASLD) Practice Guidelines are updated annually. If you are viewing a Practice Guideline that is more than 12 months old, please visit www.aasld.org for an update in the material.

Ancillary